🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
KRO
$KROS
🔒 US EquitiesKeros Therapeutics Inc
AVG HISTORICAL GAP
+0.05%
MAX GAP RECORD
+5.83%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $KROS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$KROS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 03, 2026 Earnings Release 2026-08-03 (AFTER CLOSE) |
-3.36%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
-2.09%
|
| Mar 04, 2026 Earnings Release 2026-03-04 (AFTER CLOSE) |
-5.74%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE) |
+3.07%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
-2.91%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+3.92%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE) |
+0.37%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.4%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (3)
📖 Intelligence Summary
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗